Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Olsson

Showing results (611-620 of 632) with videos related to

Pageof 64
Sort By:
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 11, 2014
Instrumentation, control and automation in wastewater--from London 1973 to Narbonne 2013G Olsson, B Carlsson, J Comas, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Kidney International|October 2, 2004
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trialBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.
Lancet (London, England)|June 20, 2003
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialHallvard Holdaas, Bengt Fellström, Alan G Jardine, et al.
Journal of the American Heart Association|January 12, 2017
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart FailureReynaria Pitts, Elise Gunzburger, Christie M Ballantyne, et al.
Plos Genetics|May 20, 2006
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Martin Farrall, Fiona R Green, John F Peden, et al.
Circulation|June 4, 2008
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatmentJohn J P Kastelein, Wim A van der Steeg, Ingar Holme, et al.
Pageof 64

Showing results (611-620 of 632) with videos related to

Sort By:
Pageof 64
Circulation|May 12, 1998
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)T R Pedersen, A G Olsson, O Faergeman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 1, 2024
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMIKatarina Mars, Sophia Humphries, Philip Leissner, et al.
Journal of Cardiovascular Risk|April 28, 2001
Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol in Renal Transplantation) study design and baseline dataH Holdaas, B Fellström, I Holme, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 11, 2014
Instrumentation, control and automation in wastewater--from London 1973 to Narbonne 2013G Olsson, B Carlsson, J Comas, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Kidney International|October 2, 2004
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trialBengt Fellström, Hallvard Holdaas, Alan G Jardine, et al.
Lancet (London, England)|June 20, 2003
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trialHallvard Holdaas, Bengt Fellström, Alan G Jardine, et al.
Journal of the American Heart Association|January 12, 2017
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart FailureReynaria Pitts, Elise Gunzburger, Christie M Ballantyne, et al.
Plos Genetics|May 20, 2006
Genome-wide mapping of susceptibility to coronary artery disease identifies a novel replicated locus on chromosome 17Martin Farrall, Fiona R Green, John F Peden, et al.
Circulation|June 4, 2008
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatmentJohn J P Kastelein, Wim A van der Steeg, Ingar Holme, et al.
Pageof 64